Home / EMCURE.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does EMCURE.NS make money? Does EMCURE.NS have pricing power? What's the Earnings Whisper? Will EMCURE.NS profit more as the business scales? What is EMCURE.NS's management track record? Is EMCURE.NS's current price justified?

Emcure Pharmaceuticals Ltd.

₹1820.6 +$417.25 (+29.73%)

NSE · 16 Oct 2026 10:00 UTC

Previous Close

₹1836

Day Range

₹1816.2₹1849.3

Year Range

₹1306.5₹2100.7

Market Cap

345.39B

AVG Volume

176.13K

Trailing/Forward PE

34.13/22.87

PEG ratio

1.2

Dividend Yield

0.20%

Next Earnings Date

2026-11-03

Primary Exchange

National Stock Exchange of India

Revenue (INR) · Q

EMCURE.NS Revenue (INR) by quarter
Period	Revenue (INR)
26 Q1	25.8B
25 Q4	24.7B
25 Q3	23.63B
25 Q2	22.7B
25 Q1	21.01B
24 Q4	20.29B
24 Q3	19.63B
24 Q2	20.02B

Net Income (INR) · Q

EMCURE.NS Net Income (INR) by quarter
Period	Net Income (INR)
26 Q1	2.94B
25 Q4	2.43B
25 Q3	2.31B
25 Q2	2.43B
25 Q1	2.07B
24 Q4	1.89B
24 Q3	1.54B
24 Q2	1.95B

Operating Income (INR) · Q

EMCURE.NS Operating Income (INR) by quarter
Period	Operating Income (INR)
26 Q1	3.98B
25 Q4	3.79B
25 Q3	3.55B
25 Q2	3.34B
25 Q1	3.04B
24 Q4	2.93B
24 Q3	2.65B
24 Q2	2.84B

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (INR) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Emcure Pharmaceuticals Ltd.

Video analysis: EMCURE.NS

News: EMCURE.NS

Similar companies